JB Chemicals and Pharmaceuticals Ltd: Drug Recall
Recall #D-0032-2026 · 09/12/2025
Class III: Low Risk
Recall Details
- Recall Number
- D-0032-2026
- Classification
- Class III
- Product Type
- Drug
- Recalling Firm
- JB Chemicals and Pharmaceuticals Ltd
- Status
- Ongoing
- Date Initiated
- 09/12/2025
- Location
- Mumbai, India
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 9936 bottles
Reason for Recall
Tablet/Capsules Imprinted with Wrong ID
Product Description
Cetirizine Hydrochloride Tablets USP 10 mg, 100 Tablets bottles, Manufactured by: Unique Pharmaceuticals Labs, (A Div. of J.B. Chemicals & Pharmaceuticals, Ltd.), Mumbai 400 030, India. Distributed by: Rising Pharma Holdings, Inc., East Brunswick, NJ 08816, NDC 16571-402-10.
Distribution Pattern
U.S. Nationwide
Other Recalls by JB Chemicals and Pharmaceuticals Ltd
- Class III: Low Risk 09/12/2025
Data from FDA openFDA enforcement reports. This site is not affiliated with or endorsed by the FDA. Recall information may be updated by the FDA at any time.